Earnings

SenesTech Receives Nasdaq Noncompliance Letter; Preliminary Q3 Revenue ~$1.1M

Oct 22, 2026 · 12:33 PM ET· updated 1h ago

SenesTech, Inc. (NASDAQ:SNES), the leader in rodent birth control and sustainable rodent population management, today announced that, on Oct. 20, 2026, it received a letter from the listing qualifications staff of The

Why It Matters

SenesTech got a warning letter from Nasdaq about following stock exchange rules. When a company gets this notice, it means investors should watch if the company fixes the problem soon.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

SNES0.79

+0.04 (+5.35%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.